These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37697210)

  • 1. The role of cytoreductive surgery in multifocal/multicentric glioblastomas.
    Dimov D; Brainman D; Berger B; Coras R; Grote A; Simon M
    J Neurooncol; 2023 Sep; 164(2):447-459. PubMed ID: 37697210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection versus biopsy in the treatment of multifocal glioblastoma: a weighted survival analysis.
    Di L; Heath RN; Shah AH; Sanjurjo AD; Eichberg DG; Luther EM; de la Fuente MI; Komotar RJ; Ivan ME
    J Neurooncol; 2020 May; 148(1):155-164. PubMed ID: 32394325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article.
    Hassaneen W; Levine NB; Suki D; Salaskar AL; de Moura Lima A; McCutcheon IE; Prabhu SS; Lang FF; DeMonte F; Rao G; Weinberg JS; Wildrick DM; Aldape KD; Sawaya R
    J Neurosurg; 2011 Mar; 114(3):576-84. PubMed ID: 20690813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There a Role for Surgical Resection of Multifocal Glioblastoma? A Retrospective Analysis of 100 Patients.
    Friso F; Rucci P; Rosetti V; Carretta A; Bortolotti C; Ramponi V; Martinoni M; Palandri G; Zoli M; Badaloni F; Franceschi E; Asioli S; Fabbri VP; Rustici A; Foschini MP; Brandes AA; Mazzatenta D; Sturiale C; Conti A
    Neurosurgery; 2021 Nov; 89(6):1042-1051. PubMed ID: 34662898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of care and survival in patients with multifocal glioblastoma: A Danish cohort study.
    Trip AK; Hedegaard Dahlrot R; Aaquist Haslund C; Muhic A; Rosendal Korshøj A; Laursen RJ; Rom Poulsen F; Skjøth-Rasmussen J; Lukacova S
    Neurooncol Pract; 2024 Aug; 11(4):421-431. PubMed ID: 39006522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased CD8
    Wang R; Song Y; Hu T; Wang X; Jiang Y; Zhang D; Yu J; Han S; Kan L
    Front Oncol; 2021; 11():748277. PubMed ID: 34646781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly Diagnosed Multifocal GBM: A Monocentric Experience and Literature Review.
    Baro V; Cerretti G; Todoverto M; Della Puppa A; Chioffi F; Volpin F; Causin F; Busato F; Fiduccia P; Landi A; d'Avella D; Zagonel V; Denaro L; Lombardi G
    Curr Oncol; 2022 May; 29(5):3472-3488. PubMed ID: 35621670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the Prognosis of Multifocal Glioblastoma: An Evaluation Incorporating Volumetric MRI.
    Kasper J; Hilbert N; Wende T; Fehrenbach MK; Wilhelmy F; Jähne K; Frydrychowicz C; Hamerla G; Meixensberger J; Arlt F
    Curr Oncol; 2021 Apr; 28(2):1437-1446. PubMed ID: 33917207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.
    Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP
    Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility, Safety and Impact on Overall Survival of Awake Resection for Newly Diagnosed Supratentorial
    Moiraghi A; Roux A; Peeters S; Pelletier JB; Baroud M; Trancart B; Oppenheim C; Lechapt E; Benevello C; Parraga E; Varlet P; Chrétien F; Dezamis E; Zanello M; Pallud J
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and recurrence patterns of multifocal glioblastoma after radiation therapy.
    Syed M; Liermann J; Verma V; Bernhardt D; Bougatf N; Paul A; Rieken S; Debus J; Adeberg S
    Cancer Manag Res; 2018; 10():4229-4235. PubMed ID: 30323678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of patients with multifocal glioblastoma: a case-control study.
    Patil CG; Yi A; Elramsisy A; Hu J; Mukherjee D; Irvin DK; Yu JS; Bannykh SI; Black KL; Nuño M
    J Neurosurg; 2012 Oct; 117(4):705-11. PubMed ID: 22920963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
    Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
    J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.
    Kreth FW; Thon N; Simon M; Westphal M; Schackert G; Nikkhah G; Hentschel B; Reifenberger G; Pietsch T; Weller M; Tonn JC;
    Ann Oncol; 2013 Dec; 24(12):3117-23. PubMed ID: 24130262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
    Molinaro AM; Hervey-Jumper S; Morshed RA; Young J; Han SJ; Chunduru P; Zhang Y; Phillips JJ; Shai A; Lafontaine M; Crane J; Chandra A; Flanigan P; Jahangiri A; Cioffi G; Ostrom Q; Anderson JE; Badve C; Barnholtz-Sloan J; Sloan AE; Erickson BJ; Decker PA; Kosel ML; LaChance D; Eckel-Passow J; Jenkins R; Villanueva-Meyer J; Rice T; Wrensch M; Wiencke JK; Oberheim Bush NA; Taylor J; Butowski N; Prados M; Clarke J; Chang S; Chang E; Aghi M; Theodosopoulos P; McDermott M; Berger MS
    JAMA Oncol; 2020 Apr; 6(4):495-503. PubMed ID: 32027343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas.
    Gessler F; Bernstock JD; Braczynski A; Lescher S; Baumgarten P; Harter PN; Mittelbronn M; Wu T; Seifert V; Senft C
    Neurosurgery; 2019 Jan; 84(1):190-197. PubMed ID: 29617848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
    Farrell C; Shi W; Bodman A; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):269-359. PubMed ID: 33215345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
    McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
    J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.